These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 22941191)
1. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Diskin SJ; Capasso M; Schnepp RW; Cole KA; Attiyeh EF; Hou C; Diamond M; Carpenter EL; Winter C; Lee H; Jagannathan J; Latorre V; Iolascon A; Hakonarson H; Devoto M; Maris JM Nat Genet; 2012 Oct; 44(10):1126-30. PubMed ID: 22941191 [TBL] [Abstract][Full Text] [Related]
2. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility. Capasso M; Diskin SJ; Totaro F; Longo L; De Mariano M; Russo R; Cimmino F; Hakonarson H; Tonini GP; Devoto M; Maris JM; Iolascon A Carcinogenesis; 2013 Mar; 34(3):605-11. PubMed ID: 23222812 [TBL] [Abstract][Full Text] [Related]
3. Common genetic variants in NEFL influence gene expression and neuroblastoma risk. Capasso M; Diskin S; Cimmino F; Acierno G; Totaro F; Petrosino G; Pezone L; Diamond M; McDaniel L; Hakonarson H; Iolascon A; Devoto M; Maris JM Cancer Res; 2014 Dec; 74(23):6913-24. PubMed ID: 25312269 [TBL] [Abstract][Full Text] [Related]
4. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317 [TBL] [Abstract][Full Text] [Related]
6. Lin28B and Let-7 in the Control of Sympathetic Neurogenesis and Neuroblastoma Development. Hennchen M; Stubbusch J; Abarchan-El Makhfi I; Kramer M; Deller T; Pierre-Eugene C; Janoueix-Lerosey I; Delattre O; Ernsberger U; Schulte JB; Rohrer H J Neurosci; 2015 Dec; 35(50):16531-44. PubMed ID: 26674877 [TBL] [Abstract][Full Text] [Related]
7. Potentially functional polymorphisms in the LIN28B gene contribute to neuroblastoma susceptibility in Chinese children. He J; Yang T; Zhang R; Zhu J; Wang F; Zou Y; Xia H J Cell Mol Med; 2016 Aug; 20(8):1534-41. PubMed ID: 27021521 [TBL] [Abstract][Full Text] [Related]
8. Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor. Cimmino F; Avitabile M; Diskin SJ; Vaksman Z; Pignataro P; Formicola D; Cardinale A; Testori A; Koster J; de Torres C; Devoto M; Maris JM; Iolascon A; Capasso M Int J Cancer; 2018 Dec; 143(11):2828-2837. PubMed ID: 30132831 [TBL] [Abstract][Full Text] [Related]
9. Common variants upstream of MLF1 at 3q25 and within CPZ at 4p16 associated with neuroblastoma. McDaniel LD; Conkrite KL; Chang X; Capasso M; Vaksman Z; Oldridge DA; Zachariou A; Horn M; Diamond M; Hou C; Iolascon A; Hakonarson H; Rahman N; Devoto M; Diskin SJ PLoS Genet; 2017 May; 13(5):e1006787. PubMed ID: 28545128 [TBL] [Abstract][Full Text] [Related]
10. A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis. Schnepp RW; Khurana P; Attiyeh EF; Raman P; Chodosh SE; Oldridge DA; Gagliardi ME; Conkrite KL; Asgharzadeh S; Seeger RC; Madison BB; Rustgi AK; Maris JM; Diskin SJ Cancer Cell; 2015 Nov; 28(5):599-609. PubMed ID: 26481147 [TBL] [Abstract][Full Text] [Related]
11. Common variations within Zhang Z; Zhang R; Zhu J; Wang F; Yang T; Zou Y; He J; Xia H Onco Targets Ther; 2017; 10():703-709. PubMed ID: 28223827 [TBL] [Abstract][Full Text] [Related]
12. Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival. Gamazon ER; Pinto N; Konkashbaev A; Im HK; Diskin SJ; London WB; Maris JM; Dolan ME; Cox NJ; Cohn SL J Natl Cancer Inst; 2013 Feb; 105(4):302-9. PubMed ID: 23243203 [TBL] [Abstract][Full Text] [Related]
13. EGCG Disrupts the LIN28B/Let-7 Interaction and Reduces Neuroblastoma Aggressiveness. Cocchi S; Greco V; Sidarovich V; Vigna J; Broso F; Corallo D; Zasso J; Re A; Rosatti EF; Longhi S; Defant A; Ladu F; Sanna V; Adami V; D'Agostino VG; Sturlese M; Sechi M; Aveic S; Mancini I; Sighel D; Quattrone A Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732012 [TBL] [Abstract][Full Text] [Related]
14. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Capasso M; Devoto M; Hou C; Asgharzadeh S; Glessner JT; Attiyeh EF; Mosse YP; Kim C; Diskin SJ; Cole KA; Bosse K; Diamond M; Laudenslager M; Winter C; Bradfield JP; Scott RH; Jagannathan J; Garris M; McConville C; London WB; Seeger RC; Grant SF; Li H; Rahman N; Rappaport E; Hakonarson H; Maris JM Nat Genet; 2009 Jun; 41(6):718-23. PubMed ID: 19412175 [TBL] [Abstract][Full Text] [Related]
15. Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients. Cattelani S; Defferrari R; Marsilio S; Bussolari R; Candini O; Corradini F; Ferrari-Amorotti G; Guerzoni C; Pecorari L; Menin C; Bertorelle R; Altavista P; McDowell HP; Boldrini R; Dominici C; Tonini GP; Raschellà G; Calabretta B Clin Cancer Res; 2008 Jun; 14(11):3248-53. PubMed ID: 18519749 [TBL] [Abstract][Full Text] [Related]
16. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Oldridge DA; Wood AC; Weichert-Leahey N; Crimmins I; Sussman R; Winter C; McDaniel LD; Diamond M; Hart LS; Zhu S; Durbin AD; Abraham BJ; Anders L; Tian L; Zhang S; Wei JS; Khan J; Bramlett K; Rahman N; Capasso M; Iolascon A; Gerhard DS; Guidry Auvil JM; Young RA; Hakonarson H; Diskin SJ; Look AT; Maris JM Nature; 2015 Dec; 528(7582):418-21. PubMed ID: 26560027 [TBL] [Abstract][Full Text] [Related]
17. LIN28B regulates transcription and potentiates MYCN-induced neuroblastoma through binding to ZNF143 at target gene promotors. Tao T; Shi H; Mariani L; Abraham BJ; Durbin AD; Zimmerman MW; Powers JT; Missios P; Ross KN; Perez-Atayde AR; Bulyk ML; Young RA; Daley GQ; Look AT Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16516-16526. PubMed ID: 32601179 [TBL] [Abstract][Full Text] [Related]
18. Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity. Bosse KR; Diskin SJ; Cole KA; Wood AC; Schnepp RW; Norris G; Nguyen le B; Jagannathan J; Laquaglia M; Winter C; Diamond M; Hou C; Attiyeh EF; Mosse YP; Pineros V; Dizin E; Zhang Y; Asgharzadeh S; Seeger RC; Capasso M; Pawel BR; Devoto M; Hakonarson H; Rappaport EF; Irminger-Finger I; Maris JM Cancer Res; 2012 Apr; 72(8):2068-78. PubMed ID: 22350409 [TBL] [Abstract][Full Text] [Related]
19. The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population. Zhang R; Zou Y; Zhu J; Zeng X; Yang T; Wang F; He J; Xia H Int J Med Sci; 2016; 13(2):133-8. PubMed ID: 26941572 [TBL] [Abstract][Full Text] [Related]
20. A Multi-Omics Approach Reveals Enrichment in Metabolites Involved in the Regulation of the Glutathione Pathway in LIN28B-Dependent Cancer Cells. Stocchero M; Corallo D; Bresolin S; Pantile M; Pirillo P; Bortolozzi R; Menegazzo S; Boso D; Viola G; Baraldi E; Biffi A; Giordano G; Aveic S Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]